Recent Quotes
My Watchlist
Indicators
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about CSLLY

Recent news which mentions CSLLY

Ionis Pharma Wins FDA Nod For First RNA-Targeted Therapy For Rare Genetic Swelling Disorder
Tickers BCRX CSLLY IONS KALV
Tags News Biotech TAK
From Benzinga
uniQure/ CSL Behring's Hemophilia Gene Therapy Shows Sustained Efficacy and Safety At Four Years
Tickers CSLLY NEWS QURE
Tags Trading Ideas Market News Health Care
From Benzinga
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Tickers ABBV CSLLY GILD GSK
Tags dividend yield Trading Ideas Market News
From Benzinga
GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report
Tickers CSLLY GSK NEWS SNY
Tags GSK Government CSLLY
From Benzinga
Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses
Tickers ARCT CSLLY NEWS PFE
Tags News Biotech ARCT
From Benzinga
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Tickers CSLLY NEWS PFE
Tags CSLLY Stories That Matter Benzinga
From Benzinga
Arcturus Therapeutics' Lung Disease Candidate Triggers Bullish Rating, Analyst Sees Over 200% Upside
Tickers ARCT CSLLY
Tags Expert Ideas ARCT Biotech
From Benzinga
Credit Suisse's $17B Of AT1 Debt Written Down To Zero, Richard Branson's Virgin Orbit Plans Insolvency, Court Freezes Volkswagen's Russian Assets: Today's Top Stories
Tickers BBBY CS CSLLY EADSF
Tags SNY CSLLY VWAGY
From Benzinga
Large Vaccine Players Including GSK, Moderna Prepare For Bird Flu Vaccine 'Just In Case'
Tickers CSLLY GSK MRNA SNY
Tags MRNA Large Cap Briefs
From Benzinga
Travere Therapeutics Scores Accelerated FDA Approval For Rare Kidney Disease Treatment
Tickers CSLLY LGND TVTX
Tags Benzinga General LGND
From Benzinga
FDA Approves UniQure's Hemgenix, First Hemophilia B Gene Therapy For Adults
Tickers BLUE CSLLY QURE
Tags News Eurasia BLUE
From Benzinga
Why Is Arcturus Therapeutics (ARCT) Stock Up 30% Today?
Tickers ARCT CSLLY
Tags ARCT CSLLY Market News
From InvestorPlace
Arcturus Shares Jump After Collaboration With CSL For mRNA-Based Vaccines
Tickers ARCT CSLLY
Tags Benzinga General Contracts
From Benzinga
Travere, CSL's Sparsentan Application Is Under European Review For Rare Kidney Disorder
Tickers CSLLY TVTX
Tags News TVTX Biotech
From Benzinga
CSL Posts Encouraging Data From Garadacimab In Severe Swelling Attacks
Tickers CSLLY
Tags CSLLY Biotech News
From Benzinga
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
Tickers BBIO BFRI BMY BTTX
Tags Health Care PLXP LNTH
From Benzinga
CSL Seals $11.7B Buyout Deal Of Vifor Pharma, Probably the Largest Healthcare Deal In 2021
Tickers CSLLY GNHAF GNHAY MRK
Tags News Biotech Trading Ideas
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>